MedTrace Logo

Tetracaine Compared to Placebo for Reducing Pain With Palivizumab - A Pilot Study

NCT00484393 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2015-06-19

Study results available
· View outcomes & findings →

Summary

This is a small study known as a pilot study. This pilot study is being done to see if a difference in pain from intramuscular palivizumab injection can be detected if tetracaine a topical numbing gel is used compared to no medication (placebo). If a difference is found in this pilot study, then a larger study may be done to confirm that there is a difference in pain experience.

Conditions

Interventions

DRUG

tetracaine 4% gel

tetracaine applied prior to 1 injection

DRUG

Placebo

placebo applied prior to 1 injection

Sponsors & Collaborators

  • Fraser Health

    lead OTHER

Principal Investigators

  • Brandi D Newby, BScPharm · Surrey Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
1 Month
Max Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00484393 on ClinicalTrials.gov